SI-BONE Reports 1Q19 Revenue of $15MM, +17.9% vs. 1Q18

SI-BONE reported 1Q19 revenue of USD $15MM, +17.9% vs. 1Q18.

• Reiterated 2019 guidance in the range of $65MM to $66.5MM, growth of 17% to 20%
• Received FDA 510(k) clearance for a broader indication using iFuse Bedrock
• Launched single-use decorticator products in the U.S.
• Gained positive reimbursement coverage from BCBS Alabama and converted BCBS Vermont and Highmark BCBS to exclusive coverage

Segment sales and growth on an as-reported basis ($MM):

Revenue by geographic region ($MM):

Net earnings ($MM):

Source: SI-BONE

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.